AG
ATRS

Algert Global’s Antares Pharma, Inc. ATRS Stock Holding History

Algert Global’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-268,478
Closed -$1.1M – 1448
2022
Q1 		$1.1M Buy
268,478
+126,314
+89% +$458K 0.07% 484
2021
Q4 		$508K Buy
142,164
+8,680
+7% +$30.4K 0.06% 526
2021
Q3 		$486K Buy
133,484
+9,518
+8% +$38.5K 0.06% 551
2021
Q2 		$540K Sell
123,966
-23,650
-16% -$96.3K 0.18% 176
2021
Q1 		$607K Buy
147,616
+2,740
+2% +$11.9K 0.19% 181
2020
Q4 		$578K Buy
144,876
+127,493
+733% +$412K 0.16% 202
2020
Q3 		$47K Sell
17,383
-10,588
-38% -$29.3K 0.01% 377
2020
Q2 		$77K Hold
27,971
– – 0.03% 385
2020
Q1 		$66K Buy
+27,971
New +$95.1K 0.03% 376

Other funds holding ATRS

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Algert Global's ATRS Position: Q2 2022 in Review

Algert Global sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 268,478 shares — an estimated $1.1M sold.

Algert Global first reported a position in ATRS in Q1 2020 and held it in 9 quarters. The position peaked at $1.1M in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • Algert Global reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • Algert Global sold 268,478 Antares Pharma, Inc. shares in Q2 2022, an estimated $1.1M.
  • Algert Global first reported a position in Antares Pharma, Inc. in Q1 2020 and held it in 9 quarters.
  • Algert Global's Antares Pharma, Inc. position peaked at $1.1M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Algert Global's 13F filing for Q2 2022, filed 15 Aug 2022.